In conclusion, this meta-analysis found that RASSF1A methylation testing using bronchial aspirates provides a strong diagnostic ability, particularly in excluding lung cancer, and has the potential to be used as a complementary diagnostic tool. Here, RASSF1 is linked to lung carcinoma.